Can-Fite BioPharma Ltd. (CANF)

USD 1.33

(-6.34%)

Long Term Debt Summary of Can-Fite BioPharma Ltd.

  • Can-Fite BioPharma Ltd.'s latest annual long term debt in 2023 was 13 Thousand USD , down -7.14% from previous year.
  • Can-Fite BioPharma Ltd.'s latest quarterly long term debt in 2024 Q1 was - USD , down 0.0% from previous quarter.
  • Can-Fite BioPharma Ltd. reported annual long term debt of 14 Thousand USD in 2022, down -80.28% from previous year.
  • Can-Fite BioPharma Ltd. reported annual long term debt of 71 Thousand USD in 2021, up 195.83% from previous year.
  • Can-Fite BioPharma Ltd. reported quarterly long term debt of - USD for 2024 Q1, down 0.0% from previous quarter.
  • Can-Fite BioPharma Ltd. reported quarterly long term debt of 13 Thousand USD for 2023 Q4, down -23.53% from previous quarter.

Annual Long Term Debt Chart of Can-Fite BioPharma Ltd. (2023 - 2011)

Historical Annual Long Term Debt of Can-Fite BioPharma Ltd. (2023 - 2011)

Year Long Term Debt Long Term Debt Growth
2023 13 Thousand USD -7.14%
2022 14 Thousand USD -80.28%
2021 71 Thousand USD 195.83%
2020 24 Thousand USD -38.46%
2019 39 Thousand USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%

Peer Long Term Debt Comparison of Can-Fite BioPharma Ltd.

Name Long Term Debt Long Term Debt Difference
AIM ImmunoTech Inc. 495 Thousand USD 97.374%
Ampio Pharmaceuticals, Inc. - USD -Infinity%
Armata Pharmaceuticals, Inc. 82.3 Million USD 99.984%
Actinium Pharmaceuticals, Inc. 1.57 Million USD 99.173%
Azitra, Inc. 563.69 Thousand USD 97.694%
Chromocell Therapeutics Corporation - USD -Infinity%
Calidi Biotherapeutics, Inc. 2.06 Million USD 99.369%
CEL-SCI Corporation 11.6 Million USD 99.888%
iBio, Inc. 3.5 Million USD 99.629%
Lineage Cell Therapeutics, Inc. 2.07 Million USD 99.372%
MAIA Biotechnology, Inc. - USD -Infinity%
Matinas BioPharma Holdings, Inc. 2.89 Million USD 99.551%
Navidea Biopharmaceuticals, Inc. 1.87 Million USD 99.305%
NovaBay Pharmaceuticals, Inc. 1.1 Million USD 98.827%
NanoViricides, Inc. - USD -Infinity%
Oragenics, Inc. - USD -Infinity%
BiomX Inc. 5.4 Million USD 99.759%
BiomX Inc. 5.4 Million USD 99.759%
Protalix BioTherapeutics, Inc. 4.62 Million USD 99.719%
Palatin Technologies, Inc. 163.78 Thousand USD 92.063%
Scorpius Holdings, Inc. 12.61 Million USD 99.897%